Health News Releases

August 17, 2018 10:45

GN Hearing and Google Announce Partnership to Bring Direct Mobile Streaming from Android Devices to Hearing Aids

GN Hearing and Google have today announced a new technology partnership that will make GN Hearing the first manufacturer to enable a full spectrum of direct audio streaming from Android devices to hea

August 15, 2018 22:05

2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine

From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Taipei for the top healthcare and technology event in Asia - The Healthcare+ Expo - Taiwan.

August 14, 2018 11:00

New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of

August 14, 2018 09:45

GN Hearing Announces Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution

GN Hearing today unveils the world’s first Premium-Plus hearing aid: ReSound LiNX Quattro™, designed for people who want the very best that technology has to offer and desire a brilliant sound experie

August 10, 2018 14:00

Merz Creates Americas Region, Expands Bob Rhatigan’s Leadership Role

Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as Chief Executive Officer - Americas. Expanding on his leadership of Merz’s North American

August 06, 2018 17:40

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium (GTC)—consisting of Imperial College London and the Universities of Oxford and Edinburgh—Imperial Innovations, and Oxford BioMedica

August 03, 2018 11:35

Graminex® LLC successfully challenges Serelys’ patents for use of pollen extracts in treating women's PMS and menopausal symptoms

Graminex® LLC is pleased to announce the US Patent Office has rejected Serelys’ patents for use of its pollen extracts in treating women's PMS and menopausal symptoms. In parallel reexamination pro

August 02, 2018 18:50

Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa

Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced recently the launch of the ‘In Reach Africa’ program, an initiative aimed at facilitating quality and innovative hu

August 01, 2018 17:00

Takeda Reports First Quarter FY2018 Results

Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +6.4% with growth in every region · Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology,

July 31, 2018 14:00

Impossible Foods Launches in Macau, China’s Tourist Hotspot

Impossible Foods is launching its award-winning, plant-based meat in Macau at one of the world’s hottest entertainment and dining resort complexes. Starting today, Impossible Foods’ flagship produc

July 30, 2018 11:35

KOHI concluded final course of ‘Multi-year Competency enhancement of Diagnosis and Treatment of ASD for Children for Bangladesh’

Korea Human Resource Development Institute for Health and Welfare(KOHI) announced that it had successfully finished ‘Multi-year Competency enhancement of Diagnosis and Treatment of Autism Spectrum Dis

July 26, 2018 13:45

Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in 1st Line) trial met its primary endpoint at the f

July 25, 2018 15:35

Banyan Biomarkers Announces Publication of ALERT-TBI Clinical Study Results in The Lancet Neurology

Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury (TBI), today announced the publication of the results for the ALERT-TBI study, an international, multicenter clin

July 24, 2018 09:05

Ferring’s Heat-Stable Carbetocin Could Save Thousands of Women’s Lives by Preventing Excessive Bleeding after Childbirth

Ferring Pharmaceuticals today announced new data demonstrating that its heat-stable formulation of carbetocin is as effective as the current standard of care, oxytocin, for the prevention of excessive

July 20, 2018 10:10

Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint

CARMELINA®1 (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrenc

July 19, 2018 18:40

New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced top-line results from the VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC

July 19, 2018 17:25

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease

VIEW E-MEDIA KIT (http://bit.ly/2zUquOI) - Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical

July 18, 2018 16:15

22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan

22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, yesterday responded to the Advance Notice of Prop

July 17, 2018 12:00

New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to

July 13, 2018 16:20

ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers

ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, today announced their agreement to form a new joint venture.

July 13, 2018 13:25

Dr. Yu-mi Jung of Magic Kiss Dental Clinic, Patented for orthodontic technique to improve gummy smile

Dr. Yu-mi Jung of Magic Kiss Dental Clinic acquired a patent for the technique to improve gummy smile and correct teeth at the same time. The core of this patent is that it allows for the resolutio

July 12, 2018 18:00

Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the randomized, Phase 3 TOURMALINE-MM3 study met its primary endpoint, demonstrating single-agent oral NINLARO® (ixazomib) as a m

July 12, 2018 16:15

EUSA Pharma: NICE Approves the Targeted Cancer Immunotherapy, QARZIBA®▼ (dinutuximab beta) to Treat Children with High-Risk Neuroblastoma

EUSA Pharma today welcomed a decision by the National Institute for Health and Care Excellence (NICE) to recommend the use of the targeted cancer immunotherapy, QARZIBA® (dinutuximab beta) to treat ch

July 11, 2018 17:20

President Clinton to Deliver Closing Keynote Address on Eliminating Preventable Deaths in Hospitals at the 7th Annual World Patient Safety, Science & Technology Summit

For the seventh year in a row, U.S. President Bill Clinton will address healthcare leaders and deliver the closing keynote remarks at the 7th Annual World Patient Safety, Science & Technology Summit,

July 11, 2018 10:50

Takeda Receives Clearance from the United States Federal Trade Commission for the Proposed Acquisition of Shire plc

Takeda Pharmaceutical Company Limited: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF

News by Region

News by Industry